Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37.9M
-
Number of holders
-
20
-
Total 13F shares, excl. options
-
1.8M
-
Shares change
-
-25.8K
-
Total reported value, excl. options
-
$5.53M
-
Value change
-
+$12.3K
-
Number of buys
-
13
-
Number of sells
-
-8
-
Price
-
$3.07
Significant Holders of Anixa Biosciences Inc - Common Stock (ANIX) as of Q4 2020
24 filings reported holding ANIX - Anixa Biosciences Inc - Common Stock as of Q4 2020.
Anixa Biosciences Inc - Common Stock (ANIX) has 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.8M shares
of 37.9M outstanding shares and own 4.75% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (663K shares), UBS Group AG (618K shares), GEODE CAPITAL MANAGEMENT, LLC (112K shares), BlackRock Inc. (93.9K shares), Qube Research & Technologies Ltd (78.3K shares), Bank of New York Mellon Corp (52K shares), NORTHERN TRUST CORP (49.3K shares), MORGAN STANLEY (22.6K shares), Platform Technology Partners (20K shares), and Hunter Perkins Capital Management, LLC (17.7K shares).
This table shows the top 20 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.